Robson M, Tung N, Conte P et al. OlympiAD closing Over-all survival and tolerability final results: Olaparib compared to chemotherapy procedure of physician?s decision in individuals by using a germline BRCA mutation and HER2-negative metastatic breast cancer. Ann As a result of accessible ev